HEADER VIRAL PROTEIN 29-JUL-24 9CWP TITLE LOCAL REFINEMENT OF THE SARS-COV-2 BA.2.86 RBD IN COMPLEX WITH TRI2-2 TITLE 2 MINIBINDER COMPND MOL_ID: 1; COMPND 2 MOLECULE: BA.2.86 SPIKE PROTEIN RBD; COMPND 3 CHAIN: C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PAN-VARIANT MINIPROTEIN TRI2-2; COMPND 7 CHAIN: K; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SARBECOVIRUSES, SPIKE GLYCOPROTEIN, STRUCTURAL GENOMIC, INHIBITOR, KEYWDS 2 VIRAL PROTEIN, MINIBINDER, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL KEYWDS 3 GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID EXPDTA ELECTRON MICROSCOPY AUTHOR J.LEE,D.VEESLER,SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS AUTHOR 2 DISEASE (SSGCID) REVDAT 1 21-JAN-26 9CWP 0 JRNL AUTH J.LEE,J.B.CASE,Y.J.PARK,R.RAVICHANDRAN,D.ASARNOW, JRNL AUTH 2 M.A.TORTORICI,J.T.BROWN,S.SANAPALA,L.CARTER,D.BAKER, JRNL AUTH 3 M.S.DIAMOND,D.VEESLER JRNL TITL THE COMPUTATIONALLY DESIGNED TRI2-2 MINIPROTEIN INHIBITOR JRNL TITL 2 PROTECTS AGAINST MULTIPLE SARS-COV-2 OMICRON VARIANTS. JRNL REF COMMUN BIOL 2026 JRNL REFN ESSN 2399-3642 JRNL PMID 41519898 JRNL DOI 10.1038/S42003-025-09499-2 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.200 REMARK 3 NUMBER OF PARTICLES : 299537 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9CWP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-24. REMARK 100 THE DEPOSITION ID IS D_1000286435. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 BA.2.86 RBD IN REMARK 245 COMPLEX WITH TRI2-2 MINIBINDER REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5325.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU K 71 REMARK 465 LEU K 72 REMARK 465 ALA K 73 REMARK 465 ARG K 74 REMARK 465 LYS K 75 REMARK 465 GLY K 76 REMARK 465 GLY K 77 REMARK 465 SER K 78 REMARK 465 GLU K 79 REMARK 465 ALA K 80 REMARK 465 LEU K 81 REMARK 465 GLU K 82 REMARK 465 GLU K 83 REMARK 465 LEU K 84 REMARK 465 GLU K 85 REMARK 465 LYS K 86 REMARK 465 ALA K 87 REMARK 465 LEU K 88 REMARK 465 ARG K 89 REMARK 465 GLU K 90 REMARK 465 LEU K 91 REMARK 465 LYS K 92 REMARK 465 LYS K 93 REMARK 465 SER K 94 REMARK 465 THR K 95 REMARK 465 ASP K 96 REMARK 465 GLU K 97 REMARK 465 LEU K 98 REMARK 465 GLU K 99 REMARK 465 ARG K 100 REMARK 465 SER K 101 REMARK 465 THR K 102 REMARK 465 GLU K 103 REMARK 465 GLU K 104 REMARK 465 LEU K 105 REMARK 465 GLU K 106 REMARK 465 LYS K 107 REMARK 465 ASN K 108 REMARK 465 PRO K 109 REMARK 465 SER K 110 REMARK 465 GLU K 111 REMARK 465 ASP K 112 REMARK 465 ALA K 113 REMARK 465 LEU K 114 REMARK 465 VAL K 115 REMARK 465 GLU K 116 REMARK 465 ASN K 117 REMARK 465 ASN K 118 REMARK 465 ARG K 119 REMARK 465 LEU K 120 REMARK 465 ILE K 121 REMARK 465 VAL K 122 REMARK 465 GLU K 123 REMARK 465 ASN K 124 REMARK 465 ASN K 125 REMARK 465 LYS K 126 REMARK 465 ILE K 127 REMARK 465 ILE K 128 REMARK 465 VAL K 129 REMARK 465 GLU K 130 REMARK 465 VAL K 131 REMARK 465 LEU K 132 REMARK 465 ARG K 133 REMARK 465 ILE K 134 REMARK 465 ILE K 135 REMARK 465 ALA K 136 REMARK 465 LYS K 137 REMARK 465 VAL K 138 REMARK 465 LEU K 139 REMARK 465 LYS K 140 REMARK 465 LEU K 141 REMARK 465 GLU K 142 REMARK 465 HIS K 143 REMARK 465 HIS K 144 REMARK 465 HIS K 145 REMARK 465 HIS K 146 REMARK 465 HIS K 147 REMARK 465 HIS K 148 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU C 340 CG CD OE1 OE2 REMARK 470 SER C 349 OG REMARK 470 SER C 366 OG REMARK 470 VAL C 382 CG1 CG2 REMARK 470 THR C 385 OG1 CG2 REMARK 470 SER C 408 OG REMARK 470 THR C 415 OG1 CG2 REMARK 470 ASP C 428 CG OD1 OD2 REMARK 470 THR C 430 OG1 CG2 REMARK 470 SER C 446 OG REMARK 470 LYS C 458 CG CD CE NZ REMARK 470 SER C 459 OG REMARK 470 LYS C 462 CG CD CE NZ REMARK 470 THR C 470 OG1 CG2 REMARK 470 ASN C 477 CG OD1 ND2 REMARK 470 LYS C 478 CG CD CE NZ REMARK 470 LYS C 481 CG CD CE NZ REMARK 470 LYS C 484 CG CD CE NZ REMARK 470 SER C 494 OG REMARK 470 THR C 500 OG1 CG2 REMARK 470 LEU C 517 CG CD1 CD2 REMARK 470 HIS C 519 CG ND1 CD2 CE1 NE2 REMARK 470 GLU K 1 CG CD OE1 OE2 REMARK 470 GLU K 3 CG CD OE1 OE2 REMARK 470 GLN K 5 CG CD OE1 NE2 REMARK 470 GLU K 15 CG CD OE1 OE2 REMARK 470 GLU K 19 CG CD OE1 OE2 REMARK 470 LEU K 24 CG CD1 CD2 REMARK 470 THR K 25 OG1 CG2 REMARK 470 GLU K 27 CG CD OE1 OE2 REMARK 470 MET K 42 CG SD CE REMARK 470 GLU K 45 CG CD OE1 OE2 REMARK 470 LEU K 46 CG CD1 CD2 REMARK 470 ILE K 47 CG1 CG2 CD1 REMARK 470 LYS K 48 CG CD CE NZ REMARK 470 SER K 49 OG REMARK 470 ASP K 50 CG OD1 OD2 REMARK 470 ASP K 51 CG OD1 OD2 REMARK 470 ARG K 53 CG CD NE CZ NH1 NH2 REMARK 470 GLU K 54 CG CD OE1 OE2 REMARK 470 ILE K 55 CG1 CG2 CD1 REMARK 470 ARG K 56 CG CD NE CZ NH1 NH2 REMARK 470 GLU K 57 CG CD OE1 OE2 REMARK 470 GLU K 60 CG CD OE1 OE2 REMARK 470 ARG K 64 CG CD NE CZ NH1 NH2 REMARK 470 GLU K 67 CG CD OE1 OE2 REMARK 470 GLU K 70 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE C 377 71.68 -155.07 REMARK 500 SER C 446 -3.50 75.93 REMARK 500 LEU K 2 -65.33 -102.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-45969 RELATED DB: EMDB REMARK 900 LOCAL REFINEMENT OF THE SARS-COV-2 BA.2.86 RBD IN COMPLEX WITH TRI2- REMARK 900 2 MINIBINDER DBREF 9CWP C 334 527 PDB 9CWP 9CWP 334 527 DBREF 9CWP K 1 148 PDB 9CWP 9CWP 1 148 SEQRES 1 C 193 ASN LEU CYS PRO PHE HIS GLU VAL PHE ASN ALA THR ARG SEQRES 2 C 193 PHE ALA SER VAL TYR ALA TRP ASN ARG THR ARG ILE SER SEQRES 3 C 193 ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN PHE ALA SEQRES 4 C 193 PRO PHE PHE ALA PHE LYS CYS TYR GLY VAL SER PRO THR SEQRES 5 C 193 LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA ASP SEQRES 6 C 193 SER PHE VAL ILE LYS GLY ASN GLU VAL SER GLN ILE ALA SEQRES 7 C 193 PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN TYR LYS SEQRES 8 C 193 LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP ASN SEQRES 9 C 193 SER ASN LYS LEU ASP SER LYS HIS SER GLY ASN TYR ASP SEQRES 10 C 193 TYR TRP TYR ARG LEU PHE ARG LYS SER LYS LEU LYS PRO SEQRES 11 C 193 PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA GLY SEQRES 12 C 193 ASN LYS PRO CYS LYS GLY LYS GLY PRO ASN CYS TYR PHE SEQRES 13 C 193 PRO LEU GLN SER TYR GLY PHE ARG PRO THR TYR GLY VAL SEQRES 14 C 193 GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SER PHE GLU SEQRES 15 C 193 LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 1 K 148 GLU LEU GLU GLU GLN VAL MET HIS VAL LEU ASP GLN VAL SEQRES 2 K 148 SER GLU LEU ALA HIS GLU LEU LEU HIS LYS LEU THR GLY SEQRES 3 K 148 GLU GLU LEU GLU ARG ALA ALA TYR PHE ASN TRP TRP ALA SEQRES 4 K 148 THR GLU MET MET LEU GLU LEU ILE LYS SER ASP ASP GLU SEQRES 5 K 148 ARG GLU ILE ARG GLU ILE GLU GLU GLU ALA ARG ARG ILE SEQRES 6 K 148 LEU GLU HIS LEU GLU GLU LEU ALA ARG LYS GLY GLY SER SEQRES 7 K 148 GLU ALA LEU GLU GLU LEU GLU LYS ALA LEU ARG GLU LEU SEQRES 8 K 148 LYS LYS SER THR ASP GLU LEU GLU ARG SER THR GLU GLU SEQRES 9 K 148 LEU GLU LYS ASN PRO SER GLU ASP ALA LEU VAL GLU ASN SEQRES 10 K 148 ASN ARG LEU ILE VAL GLU ASN ASN LYS ILE ILE VAL GLU SEQRES 11 K 148 VAL LEU ARG ILE ILE ALA LYS VAL LEU LYS LEU GLU HIS SEQRES 12 K 148 HIS HIS HIS HIS HIS HET NAG C 601 14 HET NAG C 602 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 2(C8 H15 N O6) HELIX 1 AA1 PHE C 338 ASN C 343 1 6 HELIX 2 AA2 SER C 349 TRP C 353 5 5 HELIX 3 AA3 TYR C 365 TYR C 369 5 5 HELIX 4 AA4 LYS C 386 ASP C 389 5 4 HELIX 5 AA5 ASN C 405 ILE C 410 5 6 HELIX 6 AA6 GLY C 416 ASN C 422 1 7 HELIX 7 AA7 SER C 438 SER C 443 1 6 HELIX 8 AA8 GLY C 502 HIS C 505 5 4 HELIX 9 AA9 LEU K 2 LEU K 20 1 19 HELIX 10 AB1 LEU K 21 LYS K 23 5 3 HELIX 11 AB2 THR K 25 SER K 49 1 25 HELIX 12 AB3 ASP K 51 GLU K 70 1 20 SHEET 1 AA1 5 ASN C 354 ILE C 358 0 SHEET 2 AA1 5 ASN C 394 LYS C 403 -1 O ALA C 397 N THR C 356 SHEET 3 AA1 5 PRO C 507 GLU C 516 -1 O TYR C 508 N ILE C 402 SHEET 4 AA1 5 GLY C 431 ASN C 437 -1 N ILE C 434 O VAL C 511 SHEET 5 AA1 5 ALA C 376 TYR C 380 -1 N TYR C 380 O GLY C 431 SHEET 1 AA2 2 CYS C 391 PHE C 392 0 SHEET 2 AA2 2 VAL C 524 CYS C 525 -1 O VAL C 524 N PHE C 392 SHEET 1 AA3 2 TRP C 452 ARG C 454 0 SHEET 2 AA3 2 LEU C 492 SER C 494 -1 O GLN C 493 N TYR C 453 SHEET 1 AA4 2 TYR C 473 GLN C 474 0 SHEET 2 AA4 2 CYS C 488 TYR C 489 -1 O TYR C 489 N TYR C 473 SSBOND 1 CYS C 336 CYS C 361 1555 1555 2.02 SSBOND 2 CYS C 379 CYS C 432 1555 1555 2.10 SSBOND 3 CYS C 391 CYS C 525 1555 1555 2.05 SSBOND 4 CYS C 480 CYS C 488 1555 1555 2.03 LINK ND2 ASN C 343 C1 NAG C 601 1555 1555 1.49 LINK ND2 ASN C 354 C1 NAG C 602 1555 1555 1.49 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 TER 1497 PRO C 527 TER 2000 GLU K 70 HETATM 2001 C1 NAG C 601 205.810 236.294 216.122 1.00 21.93 C HETATM 2002 C2 NAG C 601 205.993 235.236 217.267 1.00 22.24 C HETATM 2003 C3 NAG C 601 205.082 234.029 216.967 1.00 22.46 C HETATM 2004 C4 NAG C 601 203.623 234.517 216.887 1.00 22.67 C HETATM 2005 C5 NAG C 601 203.514 235.579 215.771 1.00 22.81 C HETATM 2006 C6 NAG C 601 202.109 236.142 215.673 1.00 22.86 C HETATM 2007 C7 NAG C 601 208.189 235.149 218.301 1.00 21.88 C HETATM 2008 C8 NAG C 601 209.620 234.707 218.327 1.00 21.82 C HETATM 2009 N2 NAG C 601 207.394 234.798 217.295 1.00 22.19 N HETATM 2010 O3 NAG C 601 205.214 233.060 218.014 1.00 22.55 O HETATM 2011 O4 NAG C 601 202.772 233.415 216.598 1.00 22.79 O HETATM 2012 O5 NAG C 601 204.422 236.693 216.053 1.00 22.17 O HETATM 2013 O6 NAG C 601 201.969 236.971 214.526 1.00 23.25 O HETATM 2014 O7 NAG C 601 207.758 235.855 219.220 1.00 21.85 O HETATM 2015 C1 NAG C 602 208.815 250.913 211.578 1.00 18.55 C HETATM 2016 C2 NAG C 602 208.716 252.327 212.247 1.00 18.44 C HETATM 2017 C3 NAG C 602 207.219 252.658 212.430 1.00 18.55 C HETATM 2018 C4 NAG C 602 206.531 252.635 211.046 1.00 18.67 C HETATM 2019 C5 NAG C 602 206.712 251.227 210.426 1.00 18.79 C HETATM 2020 C6 NAG C 602 206.070 251.127 209.055 1.00 18.97 C HETATM 2021 C7 NAG C 602 210.296 253.183 213.860 1.00 17.69 C HETATM 2022 C8 NAG C 602 210.987 253.120 215.183 1.00 16.82 C HETATM 2023 N2 NAG C 602 209.382 252.277 213.549 1.00 18.20 N HETATM 2024 O3 NAG C 602 207.083 253.954 213.022 1.00 18.60 O HETATM 2025 O4 NAG C 602 205.139 252.915 211.203 1.00 19.07 O HETATM 2026 O5 NAG C 602 208.141 250.921 210.300 1.00 18.71 O HETATM 2027 O6 NAG C 602 206.295 249.849 208.469 1.00 19.25 O HETATM 2028 O7 NAG C 602 210.589 254.090 213.069 1.00 17.76 O CONECT 22 228 CONECT 81 2001 CONECT 171 2015 CONECT 228 22 CONECT 376 769 CONECT 462 1485 CONECT 769 376 CONECT 1158 1197 CONECT 1197 1158 CONECT 1485 462 CONECT 2001 81 2002 2012 CONECT 2002 2001 2003 2009 CONECT 2003 2002 2004 2010 CONECT 2004 2003 2005 2011 CONECT 2005 2004 2006 2012 CONECT 2006 2005 2013 CONECT 2007 2008 2009 2014 CONECT 2008 2007 CONECT 2009 2002 2007 CONECT 2010 2003 CONECT 2011 2004 CONECT 2012 2001 2005 CONECT 2013 2006 CONECT 2014 2007 CONECT 2015 171 2016 2026 CONECT 2016 2015 2017 2023 CONECT 2017 2016 2018 2024 CONECT 2018 2017 2019 2025 CONECT 2019 2018 2020 2026 CONECT 2020 2019 2027 CONECT 2021 2022 2023 2028 CONECT 2022 2021 CONECT 2023 2016 2021 CONECT 2024 2017 CONECT 2025 2018 CONECT 2026 2015 2019 CONECT 2027 2020 CONECT 2028 2021 MASTER 259 0 2 12 11 0 0 6 2026 2 38 27 END